HCP0910 250/50 mcg

· Hanmi Pharmaceutical Company Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HCP0910 250/50 mcg, covering 2013-08-23 to 2013-08-23. Get the full timeline:

Most recent: Clinical Trial Update: Therapeutic Equivalence Study of HCP0910 250/50 Mcg to Seretide 250 Diskus in Asthmatic Patients [Phase 1]